Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 11, 2023

BUY
$10.1 - $11.6 $414,100 - $475,600
41,000 New
41,000 $436,000
Q4 2021

Feb 11, 2022

SELL
$10.86 - $13.95 $250,431 - $321,687
-23,060 Closed
0 $0
Q3 2021

Nov 10, 2021

SELL
$11.92 - $13.92 $445,962 - $520,788
-37,413 Reduced 61.87%
23,060 $301,000
Q2 2021

Aug 16, 2021

SELL
$10.16 - $13.11 $111,201 - $143,488
-10,945 Reduced 15.33%
60,473 $778,000
Q1 2021

May 13, 2021

BUY
$9.04 - $11.86 $169,527 - $222,410
18,753 Added 35.61%
71,418 $798,000
Q4 2020

Feb 16, 2021

BUY
$9.05 - $12.2 $476,618 - $642,513
52,665 New
52,665 $600,000
Q3 2020

Nov 13, 2020

SELL
$8.99 - $10.74 $230,242 - $275,062
-25,611 Closed
0 $0
Q2 2020

Aug 14, 2020

SELL
$9.14 - $11.97 $7,485 - $9,803
-819 Reduced 3.1%
25,611 $265,000
Q1 2020

May 14, 2020

SELL
$8.58 - $14.01 $5,268 - $8,602
-614 Reduced 2.27%
26,430 $267,000
Q4 2019

Feb 13, 2020

BUY
$8.22 - $14.0 $222,301 - $378,616
27,044 New
27,044 $360,000
Q4 2017

Feb 13, 2018

SELL
$12.16 - $14.58 $167,625 - $200,985
-13,785 Closed
0 $0
Q3 2017

Nov 13, 2017

SELL
$12.07 - $14.87 $46,529 - $57,323
-3,855 Reduced 21.85%
13,785 $217,000
Q2 2017

Aug 14, 2017

BUY
N/A
17,640
17,640 $333,000

Others Institutions Holding IRWD

About IRONWOOD PHARMACEUTICALS INC


  • Ticker IRWD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 153,231,008
  • Market Cap $541M
  • Description
  • Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...
More about IRWD
Track This Portfolio

Track Allianz Asset Management Gmb H Portfolio

Follow Allianz Asset Management Gmb H and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Allianz Asset Management Gmb H, based on Form 13F filings with the SEC.

News

Stay updated on Allianz Asset Management Gmb H with notifications on news.